Retension Pharmaceuticals prices IPO at $12 per share on Nasdaq
Related news
-
Hurricane Isaias strengthens as US Gulf Coast prepares for landfall
-
Troye Sivan, Jadakiss And Hasan Minhaj Lead This Week’s Smartest Music Marketing Moves
- Delta expects $5.10-$5.60 EPS and ~$2.5B free cash flow for 2026 amid projected $4.25 fuel
-
Why is CNH Industrial stock sliding today?
-
Trump says Russia to supply diesel to US and global market
-
Why is Deere & Company stock sliding today?
-
Olin Corp stock hits 52-week low at 14.94 USD
-
Junk bonds are 'flashing yellow.' Watch these warning signs